Literature DB >> 10691185

Molecular composition of progenitor toxin produced by Clostridium botulinum type C strain 6813.

T Watanabe1, Y Sagane, H Kouguchi, H Sunagawa, K Inoue, Y Fujinaga, K Oguma, T Ohyama.   

Abstract

The molecular composition of the purified progenitor toxin produced by a Clostridium botulinum type C strain 6813 (C-6813) was analyzed. The strain produced two types of progenitor toxins (M and L). Purified L toxin is formed by conjugation of the M toxin (composed of a neurotoxin and a non-toxic nonhemagglutinin) with additional hemagglutinin (HA) components. The dual cleavage sites at loop region of the dichain structure neurotoxin were identified between Arg444-Ser445 and Lys449-Thr450 by the analyses of C-terminal of the light chain and N-terminal of the heavy chain. Analysis of partial amino acid sequences of fragments generated by limited proteolysis of the neurotoxin has shown to that the neurotoxin protein produced by C-6813 was a hybrid molecule composed of type C and D neurotoxins as previously reported. HA components consist of a mixture of several subcomponents with molecular weights of 70-, 55-, 33-, 26 through 21- and 17-kDa. The N-terminal amino acid sequences of 70-, 55-, and 26 through 21-kDa proteins indicated that the 70-kDa protein was intact HA-70 gene product, and other 55- and 26 through 21-kDa proteins were derived from the 70-kDa protein by modification with proteolysis after translation of HA-70 gene. Furthermore, several amino acid differences were exhibited in the amino acid sequence as compared with the deduced sequence from the nucleotide sequence of the HA-70 gene which was common among type C (strains C-St and C-468) and D progenitor toxins (strains D-CB16 and D-1873).

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10691185     DOI: 10.1023/a:1020677417356

Source DB:  PubMed          Journal:  J Protein Chem        ISSN: 0277-8033


  5 in total

1.  Characterization of toxin complex produced by a unique strain of Clostridium botulinum serotype D 4947.

Authors:  Kimiko Hasegawa; Toshihiro Watanabe; Hiroaki Sato; Yoshimasa Sagane; Shingo Mutoh; Tomonori Suzuki; Akihito Yamano; Hirokazu Kouguchi; Kouichi Takeshi; Arihide Kamaguchi; Yukako Fujinaga; Keiji Oguma; Tohru Ohyama
Journal:  Protein J       Date:  2004-08       Impact factor: 2.371

2.  Characterization of botulinum progenitor toxins by mass spectrometry.

Authors:  Harry B Hines; Frank Lebeda; Martha Hale; Ernst E Brueggemann
Journal:  Appl Environ Microbiol       Date:  2005-08       Impact factor: 4.792

3.  Effect of nicking the C-terminal region of the Clostridium botulinum serotype D neurotoxin heavy chain on its toxicity and molecular properties.

Authors:  Tomonori Suzuki; Hirokazu Kouguchi; Toshihiro Watanabe; Kimiko Hasegawa; Tohru Yoneyama; Koichi Niwa; Atsushi Nishikawa; Jae-Chul Lee; Keiji Oguma; Tohru Ohyama
Journal:  Protein J       Date:  2007-04       Impact factor: 4.000

4.  Clinical Safety and Tolerability of A2NTX, a Novel Low-Molecular-Weight Neurotoxin Derived from Botulinum Neurotoxin Subtype A2, in Comparison with Subtype A1 Toxins.

Authors:  Toshiaki Takeuchi; Tsuyoshi Okuno; Ai Miyashiro; Tomoko Kohda; Ryosuke Miyamoto; Yuishin Izumi; Shunji Kozaki; Ryuji Kaji
Journal:  Toxins (Basel)       Date:  2021-11-22       Impact factor: 4.546

5.  Detection of the HA-33 protein in botulinum neurotoxin type G complex by mass spectrometry.

Authors:  Suzanne R Kalb; Jakub Baudys; John R Barr
Journal:  BMC Microbiol       Date:  2015-10-23       Impact factor: 3.605

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.